Egalet Corp. last week announced the licensing and acquisition of two pain products. Egalet has agreed to license worldwide rights to Oxaydo (oxycodone HCI, USP) tablets for oral use only -CII, the first and only approved immediate-release oxycodone product formulated to deter abuse via snorting from Acura Pharmaceuticals, the company stated.
Prasco Labs., Takeda Pharmacuetical Company Limited and Takeda's wholly owned subsidiary Takeda Pharmaceuticals U.S.A. on Tuesday announced that Prasco and TPUSA entered into a distribution and supply agreement for the rights to distribute colchicine tablets, USP, the authorized generic of Colcrys tablets.
HealthPrize Technologies on Tuesday reported that its medication adherence solution helped increase mean prescription fill rates by 54% and materially decreased the mean interval between refills for one group of diabetic patients by 39%.
Tops Friendly Markets, a grocer in upstate New York, northern Pennsylvania and western Vermont, is closing pharmacy departments in 27 of its 162 locations this month and transferring pharmacy prescriptions and inventory to five CVS/Pharmacy and 22 Rite Aid locations near each affected store.
In a first-of-its-kind randomized clinical trial, researchers from the Centre for Addiction and Mental Health and collaborators have shown the benefits of a personalized approach to smoking treatment, based on how quickly smokers break down nicotine in their bodies.